By conducting Western blot analysis of tumor lysates from tumors resected at a volume of ~500 mm3, we confirmed that expression of VEGFR2-Fc was maintained in RencaVEGFR2-Fc and B16F10VEGFR2-Fc tumors (Fig. 1e,f). The gene discussed is KDR; the disease is neoplasm.